- Home
- China
- World
- Europe
- Politics
- Business
- Opinions
- Tech & Sci
- Culture
- Sports
- Travel
- Nature
- Picture
- Video
- Live
- TV
- Specials
Video
22:33, 29-Apr-2020
China begins clinical trials of its fourth COVID-19 vaccine
Share
Copied
01:13
Clinical trials have started for China's fourth COVID-19 vaccine, developed by the National Vaccine and Serum Institute under the China National Biotec Group (CNBG). Since the outbreak, the CNBG has allocated one billion yuan (about 141.29 million U.S. dollars) for vaccine development.